|
|
||||||||
Ann Thorac Surg 1999;67:161-167
© 1999 The Society of Thoracic Surgeons
a Cardiothoracic Surgery, Department of Surgery, Medical College of Wisconsin, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, USA
b Department of Anesthesia, Medical College of Wisconsin, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, USA
c Department of Pediatrics, Medical College of Wisconsin, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, USA
d Department of Critical Care, Medical College of Wisconsin, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, USA
e Department of Pediatric Cardiology, Medical College of Wisconsin, Childrens Hospital of Wisconsin, Milwaukee, Wisconsin, USA
Address reprint requests to Dr Tweddell, Childrens Hospital of Wisconsin, 9000 W Wisconsin Ave, PO Box 1997, Milwaukee, WI 53201
e-mail: jstwedde{at}mcw.edu
Presented at the Thirty-fourth Annual Meeting of The Society of Thoracic Surgeons, New Orleans, LA, Jan 2628, 1998.
| Abstract |
|---|
|
|
|---|
Methods. In this prospective, nonrandomized study, oximetric catheters were placed in the superior vena cava for continuous monitoring of systemic venous oxygen saturation. Postoperative hemodynamic variables were compared between 7 control patients and 8 patients who received phenoxybenzamine.
Results. The hospital survival rate was 93% (14 of 15 patients). Improvements in postoperative hemodynamics in the phenoxybenzamine group included a higher systemic venous oxygen saturation, a narrower arteriovenous oxygen content difference, a lower ratio of pulmonary to systemic flow, and a lower indexed systemic vascular resistance. In the phenoxybenzamine group, mean arterial blood pressure was related directly to systemic oxygen delivery, in contrast to the control group, where mean arterial pressure was related directly to indexed systemic vascular resistance and the ratio of pulmonary to systemic circulation.
Conclusions. Continuous postoperative monitoring of systemic venous oxygen saturation in a patient who has undergone the Norwood procedure provides early identification of low systemic oxygen delivery and an elevated ratio of pulmonary to systemic circulation. In this pilot study, phenoxybenzamine appeared to improve systemic oxygen delivery during the early postoperative period after the Norwood procedure. Further studies are indicated to confirm these results.
| Introduction |
|---|
|
|
|---|
Recognizing that circulatory balance could not be ascertained without the measurement of both arterial and venous oxygenation, we began routinely placing intravascular optical catheters in the superior vena cava after the Norwood procedure. Our initial experience with the intravascular optical catheter, using a conventional postoperative Norwood procedure management protocol, identified an early period during which there was an increased ratio of pulmonary to systemic flow (Qp/Qs) with inadequate systemic oxygen delivery. We hypothesized that the
-blocker phenoxybenzamine (POB) would help balance the circulation by lowering the SVR and stabilizing systemic vasoconstrictor responses. We report herein the early postoperative hemodynamic profiles of newborns who underwent the Norwood procedure with or without POB.
| Material and methods |
|---|
|
|
|---|
-blocker POB on the outcome of patients undergoing the Norwood procedure, we analyzed the outcome of 15 consecutively seen patients who underwent the Norwood procedure between July 1996 and April 1997 at the Childrens Hospital of Wisconsin. The start date of inclusion was selected to coincide with the routine placement of 4-French intravascular optical catheters (Abbott Laboratories, North Chicago, IL) directly into the superior vena cava at the time of operation (Fig 1). To decrease the risk of thrombosis, no other intravenous lines were placed in the superior vena cava.
|
The superior vena cava oxygen saturation was used to approximate the systemic venous oxygen saturation (SvO2) and was the primary guide used in postoperative management. Intravascular optical catheters were placed in 5 of 7 control patients and in 8 of 8 patients who received POB. In 2 control patients, 1 with a bilateral superior vena cava and 1 with a small single right superior vena cava, intravascular optical catheter placement was not attempted. Standardized postoperative management was aimed at achieving adequate systemic oxygen delivery, defined as an SvO2 of 50% or greater, and a balanced circulation, defined as a Qp/Qs of 0.8 to 1.2. Standardized inotropic support included the routine use of milrinone (a 50-µg/kg loading dose given before weaning from cardiopulmonary bypass followed by a continuous infusion of 0.5 µg · kg-1 · min-1) and dopamine (3 µg · kg-1 · min-1). Additional inotropic support was provided as necessary with epinephrine (0.05 to 1.0 µg · kg-1 · min-1), and additional vasodilator therapy was provided as necessary with nitroprusside (0.5 to 5 µg · kg-1 · min-1). Intentional hypercapnea escalating to the addition of CO2 (1% to 4%) was used if necessary to limit excessive pulmonary blood flow.
The control patients received conventional postoperative management as outlined earlier. Phenoxybenzamine was administered according to a protocol approved by the U.S. Food and Drug Administration and the institutional review boards of the Childrens Hospital of Wisconsin and the Medical College of Wisconsin, and informed written consent was obtained for each patient. The POB protocol was adapted from the one used by Mee and associates at the Cleveland Clinic (personal communication). Eight patients received POB, 0.25 mg/kg, at the commencement of cardiopulmonary bypass; no changes were made in their postoperative management. In 5 of the 8 patients who received POB, a continuous infusion at a rate of 0.25 mg/kg every 24 hours was maintained for up to 48 hours in the immediate postoperative period. The decision to use a continuous infusion in addition to the bolus dose was based on the target of achieving adequate systemic oxygen delivery (SvO2 of >50%) and balanced circulation (Qp/Qs of 0.8 to 1.2).
Data were collected prospectively using a standardized form and compared between the control group and the POB group. Preoperative data included the anatomic diagnosis, weight, and age at the time of operation as well as the presence of additional congenital abnormalities. Operative data included the duration of circulatory arrest and shunt size. Postoperative data consisted of the SvO2, arteriovenous oxygen content difference (
AVO2), Qp/Qs, mean arterial blood pressure (MAP), SVR index (SVRI), arterial oxygen saturation (SaO2), and hemoglobin. The hemodynamic variables (
AVO2, Qp/Qs, and SVRI) were calculated using standard formulas [11]. To calculate the SVRI, an assumed oxygen consumption of 180 mL · min-1 · m-2 was used [12].
Data were recorded at hourly intervals for the first 48 hours after operation in all patients. To identify more closely interactions of hemodynamic parameters, an eight-channel analog-to-digital converter (DAP 102, Microstar Labs, Belleview, WA) and a data acquisition system (Dasy Lab, Omega Engineering, Stamford, CT) based on an IBM personal computer were used to continuously record the MAP, SaO2 SvO2, inspired oxygen concentration, end-tidal CO2, and central venous pressure in 10 of the 15 patients.
Preoperative and operative patient characteristics of the two groups were compared using the Students t-test or the Mann-Whitney rank sum test. Hemodynamic data of the two groups were compared using two-way analysis of variance with a repeated-measures factor with the post hoc Bonferroni test for between-group comparisons (RM ANOVA) and by linear regression analysis with correction for repeated measures and inclusion of POB as an interactive term (STATA software, College Station, TX). Differences were considered statistically significant at a p value of < 0.05.
| Results |
|---|
|
|
|---|
|
AVO2 was narrower (Fig 3) in the POB group during hours 1 to 10 (p < 0.05, RM ANOVA). The Qp/Qs of the control patients was elevated compared with that of the POB group during hours 1 to 10 (p < 0.05, RM ANOVA) (Fig 4). The MAP was lower in the POB group during hour 1 and hours 4 to 19 (p < 0.05, RM ANOVA) (Fig 5). The SVRI was significantly lower in the POB group during hours 1 to 15 (p < 0.05, RM ANOVA) (Fig 6). The SaO2 and hemoglobin were not significantly different between the two groups at any time during the first 48 hours; the range of mean SaO2 was 70% to 80% and the range of mean hemoglobin was 15 to 17 g/dL.
|
|
|
|
|
|
AVO2, SVRI, and Qp/Qs during the first 24 hours after operation using linear regression analysis (Fig 8). Phenoxybenzamine shifted the direction of the relation between systemic oxygen delivery and the MAP such that systemic oxygen delivery was positively correlated with the MAP in patients who received POB. The slope of SvO2 versus MAP changed from -0.90%/mm Hg in the control group to +1.48%/mm Hg in the POB group (p = 0.001). The slope of
AVO2 versus MAP changed from +0.21 mL · dL-1 · mm Hg-1 in the control group to -0.173 mL · dL-1 · mm Hg-1 in the POB group (p = 0.008). In the control group, the MAP was related directly to the Qp/Qs. Phenoxybenzamine changed the direction of this relation: the slope of the Qp/Qs changed from +0.076 L · min-1 · mm Hg-1 to -0.022 L · min-1· mm Hg-1 (p = 0.061). Although this difference did not reach statistical significance, it is noteworthy that in the POB group, the MAP was not positively related to the Qp/Qs, suggesting that POB stabilized the Qp/Qs over a wide range of MAP. The slope of SVRI versus MAP changed from +0.821 Wood units/mm Hg in the control group to -0.060 Wood units/mm Hg in the POB group (p = 0.007). Therefore, in the control group, the SVRI correlated positively with the MAP, whereas in the POB group, the SVRI was stable over a wide range of MAP.
|
| Comment |
|---|
|
|
|---|
Despite arterial saturation in the target range, excessive pulmonary blood flow and decreased systemic oxygen delivery marked the early postoperative period of the control group in this study. In addition, multiple episodes of acute elevations in the Qp/Qs with decreases in the SvO2 were identified (Fig 7). The most effective therapy for these acute episodes, which are characterized best as acute elevations of the SVR, was additional sedation with benzodiazepines or opioids, but these interventions were not uniformly effective in stabilizing the SVR. Our findings and those of others indicate that the SaO2 cannot be relied on to indicate adequate systemic oxygen delivery and a balanced circulation [13, 14]. Physical examination, particularly assessment of the peripheral pulses, also has limitations. Whereas pulses may be diminished with low total cardiac output, circulatory imbalance with a high Qp/Qs can be marked by high pulse amplitude as a result of aortopulmonary runoff.
Previous efforts at achieving a balanced circulation in the early postoperative period have focused on increasing the pulmonary vascular resistance to prevent excessive pulmonary blood flow, most commonly by limiting the fraction of inspired oxygen and inducing hypercapnia. Hypercapnia can be induced by decreasing minute ventilation, adding dead space to the ventilator circuit, and adding 1% to 4% of CO2 to the inspired gas mixture [24]. The use of supplemental CO2 was associated with improved survival after the Norwood procedure [4]. Smaller systemic to pulmonary artery shunts also have been used to limit pulmonary blood flow. The net result of increasing the pulmonary vascular resistance to achieve a balanced circulation is an increase in the total resistance, which impairs cardiac output and may have a negative impact on single ventricle function. In addition, the use of smaller systemic to pulmonary artery shunts may lead to unacceptable levels of cyanosis in young infants.
Our initial experience with the intravascular optical catheter identified the need for additional afterload reduction in the early postoperative period. Afterload reduction has two benefits: decreased total resistance results in increased total cardiac output and reduction of the SVR leads to a more balanced Qp/Qs, resulting in better partitioning of the cardiac output. Phenoxybenzamine, an irreversible
-blocker, was selected because it provides a uniform and reliable reduction in the SVR. Its long half-life (24 hours) minimizes moment-to-moment variability in afterload reduction. No other changes were made in the standard postoperative management protocol.
Significant improvements in the early postoperative course of the patients who received POB included a Qp/Qs nearer to 1, a lower SVRI, a higher SvO2, and a narrower
AVO2. These data indicate that afterload reduction with POB improved systemic oxygen delivery during the early postoperative period. This improvement was achieved with a mild reduction in the MAP. Therefore, this strategy achieved a balanced circulation by lowering the SVR rather than raising the pulmonary vascular resistance, and by providing a net increase in cardiac output. During postoperative hours 24 to 48, the POB and control groups had similar hemodynamic and oxygen delivery data. The merging of hemodynamic data during the second postoperative day after the acute intervention with POB indicates that the early differences between the two patient groups were based on the pharmacology of POB rather than on underlying physiologic or anatomic differences.
A standardized inotropic support and vasodilator protocol was used in both groups, although there was no attempt to ensure equal inotropic support in the two groups. We identified no adverse effects of POB. Specifically, we identified no episodes of arrhythmias and no evidence of myocardial ischemia. These findings are consistent with studies of POB during hypovolemic shock in which coronary blood flow was increased with POB administration even in the face of significant hypotension [15].
Our data indicate that the patients who received POB had a consistent decrease in the SVR, whereas the SVR fluctuated during the early postoperative period in the control patients. Phenoxybenzamine blocks
-receptors that are important in the sympathetic response [16]. Elevation of the SVR to maintain blood pressure in the face of decreasing systemic cardiac output is a highly preserved cardiovascular reflex. In a patient who has undergone the Norwood procedure, this reflex elevation of the SVR leads to a further decrease in systemic perfusion as the Qp/Qs increases. A positive feedback loop develops and may contribute to early death. By blocking the vasoconstrictor component of the sympathetic response,
-blockade may be uniquely suited to the postoperative management of these patients. The use of
-blockade with POB balanced the parallel circulation over the range of hemodynamic variables seen in this study (Fig 8).
Limitations of this study
Although data collection was prospective, this study was neither blinded nor randomized. In studies of this type, it is possible that nonrandom selection and unblinded evaluation can lead to results unrelated to the intervention studied [17]. However, the study protocol was designed to identify variations in a uniform group of patients who underwent the Norwood procedure over a short period (18 months). Management of the patients was consistent between the control and POB groups. The only change in management over the period of this study was the introduction of POB. Given the consistent postoperative management, uniformity of the patient groups, short period involved, and minimal comparable data in the literature, we believe the results are valuable. Further studies are indicated to confirm these results.
Conclusions
Continuous monitoring of the SvO2 after the Norwood procedure allows for early identification of inadequate systemic oxygen delivery. Maneuvers to improve systemic oxygen delivery and provide for a balanced Qp/Qs can be initiated before other indicators of low output become manifest. The addition of POB to the standard inotropic and vasodilator regimen improved early postoperative systemic oxygen delivery. Phenoxybenzamine fundamentally changed the relation between blood pressure, systemic oxygen delivery, and the Qp/Qs. The use of POB was associated with improved systemic oxygen delivery and stabilization of the Qp/Qs.
| Acknowledgments |
|---|
|
|
|---|
| Footnotes |
|---|
|
|
|---|
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
B. A. Johnson, G. M. Hoffman, J. S. Tweddell, J. R. Cava, M. Basir, M. E. Mitchell, M. C. Scanlon, K. A. Mussatto, and N. S. Ghanayem Near-infrared spectroscopy in neonates before palliation of hypoplastic left heart syndrome. Ann. Thorac. Surg., February 1, 2009; 87(2): 571 - 579. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, H. Holtby, B. Bissonnette, G. Wang, A. N. Redington, and G. S. Van Arsdell Carbon dioxide-a complex gas in a complex circulation: Its effects on systemic hemodynamics and oxygen transport, cerebral, and splanchnic circulation in neonates after the Norwood procedure. J. Thorac. Cardiovasc. Surg., November 1, 2008; 136(5): 1207 - 1214. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Hehir, T. E. Dominguez, J. A. Ballweg, C. Ravishankar, B. S. Marino, G. L. Bird, S. C. Nicolson, T. L. Spray, J. W. Gaynor, and S. Tabbutt Risk factors for interstage death after stage 1 reconstruction of hypoplastic left heart syndrome and variants J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 94 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, H. Holtby, S. Cai, M. Walsh, C. A. Caldarone, and G. S. Van Arsdell Significant correlation of comprehensive Aristotle score with total cardiac output during the early postoperative period after the Norwood procedure J. Thorac. Cardiovasc. Surg., July 1, 2008; 136(1): 123 - 128. [Abstract] [Full Text] [PDF] |
||||
![]() |
Rebuttal by Aschner and Liske J Appl Physiol, June 1, 2008; 104(6): 1839 - 1839. [Full Text] [PDF] |
||||
![]() |
E. Ebenroth Point:Counterpoint: Hypoxia is/is not the optimal means of reducing pulmonary blood flow in the preoperative single ventricle heart J Appl Physiol, June 1, 2008; 104(6): 1835 - 1836. [Full Text] [PDF] |
||||
![]() |
J. S. Tweddell, N. S. Ghanayem, K. A. Mussatto, M. E. Mitchell, L. J. Lamers, N. L. Musa, S. Berger, S. B. Litwin, and G. M. Hoffman Mixed Venous Oxygen Saturation Monitoring After Stage 1 Palliation for Hypoplastic Left Heart Syndrome Ann. Thorac. Surg., October 1, 2007; 84(4): 1301 - 1311. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, L. Benson, H. Holtby, S. Cai, T. Humpl, G. S. Van Arsdell, A. N. Redington, and C. A. Caldarone Comparison of the Profiles of Postoperative Systemic Hemodynamics and Oxygen Transport in Neonates After the Hybrid or the Norwood Procedure: A Pilot Study Circulation, September 11, 2007; 116(11_suppl): I-179 - I-187. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Stuth Phenoxybenzamine Is Indicated in Treatment of Hypoplastic Left Heart Syndrome: Pro Anesth. Analg., August 1, 2007; 105(2): 307 - 309. [Full Text] [PDF] |
||||
![]() |
N. A. Guzzetta Phenoxybenzamine in the Treatment of Hypoplastic Left Heart Syndrome: A Core Review Anesth. Analg., August 1, 2007; 105(2): 312 - 315. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Tweddell Aspirin: A Treatment for the Headache of Shunt-Dependent Pulmonary Blood Flow and Parallel Circulation? Circulation, July 17, 2007; 116(3): 236 - 237. [Full Text] [PDF] |
||||
![]() |
S. Sano New Era in Management of Hypoplastic Left Heart Syndrome Asian Cardiovasc Thorac Ann, April 1, 2007; 15(2): 83 - 85. [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, B. W. McCrindle, H. Holtby, T. Humpl, S. Cai, C. A. Caldarone, A. N. Redington, and G. S. Van Arsdell Profiles of hemodynamics and oxygen transport derived by using continuous measured oxygen consumption after the Norwood procedure J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 441 - 448. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. S. Ghanayem, R. D.B. Jaquiss, J. R. Cava, P. C. Frommelt, K. A. Mussatto, G. M. Hoffman, and J. S. Tweddell Right Ventricle-to-Pulmonary Artery Conduit Versus Blalock-Taussig Shunt: A Hemodynamic Comparison Ann. Thorac. Surg., November 1, 2006; 82(5): 1603 - 1610. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Laudito, E. M. Graham, M. R. Stroud, V. Bandisode, A. N. Bhat, F. A. Crawford Jr, A. M. Atz, and S. M. Bradley Complete repair of conotruncal defects with an interatrial communication: oxygenation, hemodynamic status, and early outcome. Ann. Thorac. Surg., October 1, 2006; 82(4): 1286 - 1291. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, G. Zhang, H. M. Holtby, B. W. McCrindle, S. Cai, T. Humpl, C. A. Caldarone, W. G. Williams, A. N. Redington, and G. S. Van Arsdell Inclusion of oxygen consumption improves the accuracy of arterial and venous oxygen saturation interpretation after the Norwood procedure J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1099 - 1107. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Stieh, G. Fischer, J. Scheewe, A. Uebing, P. Dutschke, O. Jung, R. Grabitz, H. J. Trampisch, and H. H. Kramer Impact of preoperative treatment strategies on the early perioperative outcome in neonates with hypoplastic left heart syndrome J. Thorac. Cardiovasc. Surg., May 1, 2006; 131(5): 1122 - 1129. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Photiadis, N. Sinzobahamvya, C. Fink, M. Schneider, E. Schindler, A. M. Brecher, A. E. Urban, and B. Asfour Optimal pulmonary to systemic blood flow ratio for best hemodynamic status and outcome early after Norwood operation. Eur. J. Cardiothorac. Surg., April 1, 2006; 29(4): 551 - 556. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Photiadis, B. Asfour, N. Sinzobahamvya, C. Fink, E. Schindler, A.-M. Brecher, and A. E. Urban Improved Hemodynamics and Outcome After Modified Norwood Operation on the Beating Heart Ann. Thorac. Surg., March 1, 2006; 81(3): 976 - 981. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Asfour, C. Fink, N. Sinzobahamvya, J. Wetter, A. E. Urban, and J. Photiadis Modified Children's II Operation on the Beating Heart Allows Growth Potential Ann. Thorac. Surg., October 1, 2005; 80(4): e14 - e16. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, K. A. Mussatto, C. L. Brosig, N. S. Ghanayem, N. Musa, R. T. Fedderly, R. D.B. Jaquiss, and J. S. Tweddell Systemic venous oxygen saturation after the Norwood procedure and childhood neurodevelopmental outcome J. Thorac. Cardiovasc. Surg., October 1, 2005; 130(4): 1094 - 1100. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Photiadis, M. Hubler, N. Sinzobahamvya, S. Ovroutski, B. Stiller, R. Hetzer, A. E. Urban, and B. Asfour Does size matter? Larger Blalock-Taussig shunt in the modified Norwood operation correlates with better hemodynamics Eur. J. Cardiothorac. Surg., July 1, 2005; 28(1): 56 - 60. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Photiadis, A. E. Urban, N. Sinzobahamvya, C. Fink, E. Schindler, M. Schneider, A. M. Brecher, and B. Asfour Restrictive left atrial outflow adversely affects outcome after the modified Norwood procedure Eur. J. Cardiothorac. Surg., June 1, 2005; 27(6): 962 - 967. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Rumball, S. P. McGuirk, O. Stumper, S. J. Laker, J. V. de Giovanni, J. G. Wright, D. J. Barron, and W. J. Brawn The RV-PA conduit stimulates better growth of the pulmonary arteries in hypoplastic left heart syndrome Eur. J. Cardiothorac. Surg., May 1, 2005; 27(5): 801 - 806. [Abstract] [Full Text] [PDF] |
||||
![]() |
U Theilen and L Shekerdemian The intensive care of infants with hypoplastic left heart syndrome Arch. Dis. Child. Fetal Neonatal Ed., March 1, 2005; 90(2): F97 - F102. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Soetenga and K. A. Mussatto Management of Infants With Hypoplastic Left Heart Syndrome: Integrating Research Into Nursing Practice Crit. Care Nurse, December 1, 2004; 24(6): 46 - 66. [Full Text] [PDF] |
||||
![]() |
C. Pizarro, T. Mroczek, E. Malec, and W. I. Norwood Right Ventricle to Pulmonary Artery Conduit Reduces Interim Mortality After Stage 1 Norwood for Hypoplastic Left Heart Syndrome Ann. Thorac. Surg., December 1, 2004; 78(6): 1959 - 1964. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. C. De Oliveira, D. A. Ashburn, F. Khalid, H. M. Burkhart, I. T. Adatia, H. M. Holtby, W. G. Williams, and G. S. Van Arsdell Prevention of Early Sudden Circulatory Collapse After the Norwood Operation Circulation, September 14, 2004; 110(11_suppl_1): II-133 - II-138. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bradley, J. M. Simsic, T. C. McQuinn, D. M. Habib, G. S. Shirali, and A. M. Atz Hemodynamic status after the Norwood procedure: A comparison of right ventricle-to-pulmonary artery connection versus modified blalock-taussig shunt Ann. Thorac. Surg., September 1, 2004; 78(3): 933 - 941. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Nakano, H. Kado, Y. Shiokawa, K. Fukae, Y. Nishimura, K. Miyamoto, Y. Tanoue, H. Tatewaki, and N. Fusazaki The low resistance strategy for the perioperative management of the Norwood procedure Ann. Thorac. Surg., March 1, 2004; 77(3): 908 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, J. S. Tweddell, N. S. Ghanayem, K. A. Mussatto, E. A. Stuth, R. D. B. Jaquis, and S. Berger Alteration of the critical arteriovenous oxygen saturation relationship by sustained afterload reduction after the norwood procedure J. Thorac. Cardiovasc. Surg., March 1, 2004; 127(3): 738 - 745. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bradley, A. M. Atz, and J. M. Simsic Redefining the impact of oxygen and hyperventilation after the Norwood procedure J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 473 - 480. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. E. Wright, D. C. Crowley, J. R. Charpie, R. G. Ohye, E. L. Bove, and T. J. Kulik High systemic vascular resistance and sudden cardiovascular collapse in recovering norwood patients Ann. Thorac. Surg., January 1, 2004; 77(1): 48 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, E. A. Stuth, R. D. Jaquiss, P. L. Vanderwal, S. R. Staudt, T. J. Troshynski, N. S. Ghanayem, and J. S. Tweddell Changes in cerebral and somatic oxygenation during stage 1 palliation of hypoplastic left heart syndrome using continuous regional cerebral perfusion J. Thorac. Cardiovasc. Surg., January 1, 2004; 127(1): 223 - 233. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.S. Ghanayem, G.M. Hoffman, K.A. Mussatto, J.R. Cava, P.C. Frommelt, N.A. Rudd, M.M. Steltzer, S.M. Bevandic, S.J. Frisbee, R.D.B. Jaquiss, et al. Home surveillance program prevents interstage mortality after the Norwood procedure J. Thorac. Cardiovasc. Surg., November 1, 2003; 126(5): 1367 - 1375. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pizarro, E. Malec, K. O. Maher, K. Januszewska, S. S. Gidding, K. A. Murdison, J. M. Baffa, and W. I. Norwood Right Ventricle to Pulmonary Artery Conduit Improves Outcome After Stage I Norwood for Hypoplastic Left Heart Syndrome Circulation, September 9, 2003; 108(90101): II-155 - 160. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. O. Maher, C. Pizarro, S. S. Gidding, K. Januszewska, E. Malec, W. I. Norwood Jr, and J. D. Murphy Hemodynamic Profile After the Norwood Procedure With Right Ventricle to Pulmonary Artery Conduit Circulation, August 19, 2003; 108(7): 782 - 784. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Sano, K. Ishino, M. Kawada, S. Arai, S. Kasahara, T. Asai, Z.-i. Masuda, M. Takeuchi, and S.-i. Ohtsuki Right ventricle-pulmonary artery shunt in first-stage palliation of hypoplastic left heart syndrome J. Thorac. Cardiovasc. Surg., August 1, 2003; 126(2): 504 - 510. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pizarro and W. I. Norwood Right ventricle to pulmonary artery conduit has a favorable impact on postoperative physiology after Stage I Norwood: preliminary results Eur. J. Cardiothorac. Surg., June 1, 2003; 23(6): 991 - 995. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Malec, K. Januszewska, J. Kolcz, and T. Mroczek Right ventricle-to-pulmonary artery shunt versus modified Blalock-Taussig shunt in the Norwood procedure for hypoplastic left heart syndrome - influence on early and late haemodynamic status Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 728 - 734. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Pizarro and W. I. Norwood Pulmonary artery banding before Norwood procedure Ann. Thorac. Surg., March 1, 2003; 75(3): 1008 - 1010. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Kaneko, Y. Hirata, K. Yagyu, A. Murakami, and S. Takamoto Pulmonary-to-systemic blood flow ratio oriented management after repair of obstructive total anomalous pulmonary venous connection in neonates with single ventricle Ann. Thorac. Surg., March 1, 2003; 75(3): 1010 - 1012. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Tweddell, G. M. Hoffman, K. A. Mussatto, R. T. Fedderly, S. Berger, R. D. B. Jaquiss, N. S. Ghanayem, S. J. Frisbee, and S. B. Litwin Improved Survival of Patients Undergoing Palliation of Hypoplastic Left Heart Syndrome: Lessons Learned From 115 Consecutive Patients Circulation, September 24, 2002; 106(12_suppl_1): I-82 - I-89. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. B. O'Blenes, N. Roy, I. Konstantinov, D. Bohn, and G. S. Van Arsdell Vasopressin reversal of phenoxybenzamine-induced hypotension after the Norwood procedure J. Thorac. Cardiovasc. Surg., May 1, 2002; 123(5): 1012 - 1013. [Full Text] [PDF] |
||||
![]() |
J. M. Pearl, D. P. Nelson, S. M. Schwartz, and P. B. Manning First-stage palliation for hypoplastic left heart syndrome in the twenty-first century Ann. Thorac. Surg., January 1, 2002; 73(1): 331 - 339. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Bradley, J. M. Simsic, and A. M. Atz Hemodynamic effects of inspired carbon dioxide after the Norwood procedure Ann. Thorac. Surg., December 1, 2001; 72(6): 2088 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Azakie, S. L. Merklinger, B. W. McCrindle, G. S. Van Arsdell, K.-J. Lee, L. N. Benson, J. G. Coles, and W. G. Williams Evolving strategies and improving outcomes of the modified Norwood procedure: a 10-year single-institution experience Ann. Thorac. Surg., October 1, 2001; 72(4): 1349 - 1353. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Taeed, S. M. Schwartz, J. M. Pearl, J. L. Raake, R. H. Beekman III, P. B. Manning, and D. P. Nelson Unrecognized Pulmonary Venous Desaturation Early After Norwood Palliation Confounds Gp:Gs Assessment and Compromises Oxygen Delivery Circulation, June 5, 2001; 103(22): 2699 - 2704. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. M. Hoffman, N. S. Ghanayem, J. M. Kampine, S. Berger, K. A. Mussatto, S. B. Litwin, and J. S. Tweddell Venous saturation and the anaerobic threshold in neonates after the Norwood procedure for hypoplastic left heart syndrome Ann. Thorac. Surg., November 1, 2000; 70(5): 1515 - 1520. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Rychik, D. M. Bush, T. L. Spray, J. W. Gaynor, and G. Wernovsky Assessment of pulmonary/systemic blood flow ratio after first-stage palliation for hypoplastic left heart syndromeDevelopment of a new index with the use of doppler echocardiography J. Thorac. Cardiovasc. Surg., July 1, 2000; 120(1): 81 - 87. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Tweddell, G. M. Hoffman, R. T. Fedderly, N. S. Ghanayem, J. M. Kampine, S. Berger, K. A. Mussatto, and S. B. Litwin Patients at risk for low systemic oxygen delivery after the Norwood procedure Ann. Thorac. Surg., June 1, 2000; 69(6): 1893 - 1899. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |